Linked from

The 15 pages that link to Hepatocellular carcinoma, each with the reason it gives.

• Liver transplantationRelated: Selected patients with this cancer may qualify for transplantation within defined criteria.

• CirrhosisRelated: Cirrhosis increases cancer risk, prompting regular surveillance for this tumor.

• Hepatitis BRelated: HBV can raise liver-cancer risk even before cirrhosis develops.

• HepatocyteBroader topic: This cancer develops from the cell type that makes up most liver tissue.

• Hepatitis CBroader topic: Chronic infection and cirrhosis increase the risk of this liver cancer.

• Hepatitis B virusRelated: HBV can cause this cancer even without established cirrhosis.

• Iron overloadRelated: Iron-related cirrhosis increases the risk of this liver cancer.

• AflatoxinRelated: Chronic aflatoxin exposure is a major risk factor, especially alongside hepatitis B infection.

• Primary biliary cholangitisRelated: Risk rises particularly when the disease has progressed to cirrhosis, guiding surveillance decisions.

• Hepatitis C virusRelated: Chronic HCV infection raises liver-cancer risk, especially after cirrhosis develops.

• Hepatitis DRelated: Long-term HDV, usually alongside HBV, increases the risk of this liver cancer.

• Liver cancerBroader topic: It is the most common primary liver cancer.

• Baruch Samuel BlumbergRelated: Preventing hepatitis B through vaccination also reduces this cancer’s incidence.

• Non-alcoholic fatty liver diseaseRelated: Advanced disease can raise liver cancer risk, sometimes even before cirrhosis.

• DurvalumabBroader topic: Durvalumab is used with tremelimumab in a first-line regimen for unresectable disease.